These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 8127986)

  • 1. Regression of transitional cell carcinoma of the bladder with radiotherapy: progression-free control in the bladder at 5 years.
    Bessell EM; Taylor J; Moloney AJ; Lemberger J
    Radiother Oncol; 1993 Dec; 29(3):344-6. PubMed ID: 8127986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of locally advanced carcinoma of the urinary bladder with preoperative radiotherapy and radical cystectomy versus radical cystectomy alone].
    Smith JA; Crawfort ED; Paradelo JC; Blumenstein B; Herschman BR; Grossman HB; Christie DW
    Urologe A; 1998 Sep; 37(5):532-3. PubMed ID: 9796037
    [No Abstract]   [Full Text] [Related]  

  • 3. [Combination of endoscopic resection and external radiotherapy in carcinoma of the bladder].
    Kahlain A; Bouras N; Sahraoui S; Acharki A; Benider A; Samlali R
    Cancer Radiother; 1998 Apr; 2 Suppl 1():31s-33s. PubMed ID: 9749075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Infiltrating transitional carcinoma of the bladder (I). Comparison of 2 groups treated with preoperative radiotherapy (long-term protocol and short-term protocol) + radical cystectomy versus radical cystectomy only. Analysis of local recurrence and metastasis].
    Escudero Barrilero A; Allona A; Berenguer A; Burgos J; Castañeda A; Negrin A; Tellez M
    Actas Urol Esp; 1991; 15(2):124-38. PubMed ID: 1807106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of bladder-conserving treatment, consisting of brachytherapy combined with limited surgery and external beam radiotherapy, for patients with solitary T1-T3 bladder tumors less than 5 cm in diameter.
    Blank LE; Koedooder K; van Os R; van de Kar M; van der Veen JH; Koning CC
    Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):454-8. PubMed ID: 17560734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concurrent platinum and docetaxel chemotherapy and external radical radiotherapy in patients with invasive transitional cell bladder carcinoma. A preliminary report of tolerance and local control.
    Varveris H; Delakas D; Anezinis P; Haldeopoulos D; Mazonakis M; Damilakis J; Metaxaris G; Chondros N; Mavromanolakis E; Daskalopoulos G; Dimitrakopoulos A; Kranidis A
    Anticancer Res; 1997; 17(6D):4771-80. PubMed ID: 9494605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radical radiotherapy for muscle invasive transitional cell carcinoma of the bladder: failure analysis.
    Gospodarowicz MK; Hawkins NV; Rawlings GA; Connolly JG; Jewett MA; Thomas GM; Herman JG; Garrett PG; Chua T; Duncan W
    J Urol; 1989 Dec; 142(6):1448-53; discussion 1453-4. PubMed ID: 2585617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The fate of patients with locally advanced bladder cancer treated conservatively with neoadjuvant chemotherapy, extensive transurethral resection and radiotherapy: 10-year experience.
    Serretta V; Lo Greco G; Pavone C; Pavone-Macaluso M
    J Urol; 1998 Apr; 159(4):1187-91. PubMed ID: 9507829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton beam therapy for invasive bladder cancer: a prospective study of bladder-preserving therapy with combined radiotherapy and intra-arterial chemotherapy.
    Hata M; Miyanaga N; Tokuuye K; Saida Y; Ohara K; Sugahara S; Kagei K; Igaki H; Hashimoto T; Hattori K; Shimazui T; Akaza H; Akine Y
    Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1371-9. PubMed ID: 16580495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concurrent cisplatin, 5-fluorouracil, leucovorin, and radiotherapy for invasive bladder cancer.
    Chen WC; Liaw CC; Chuang CK; Chen MF; Chen CS; Lin PY; Chang PL; Chu SH; Wu CT; Hong JH
    Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):726-33. PubMed ID: 12788178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiotherapy may improve overall survival of patients with T3/T4 transitional cell carcinoma of the renal pelvis or ureter and delay bladder tumour relapse.
    Chen B; Zeng ZC; Wang GM; Zhang L; Lin ZM; Sun LA; Zhu TY; Wu LL; Zhang JY; Ji Y
    BMC Cancer; 2011 Jul; 11():297. PubMed ID: 21756352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urethral recurrence after radical radiotherapy for bladder cancer.
    Cresswell J; Roberts JT; Neal DE
    J Urol; 2001 Apr; 165(4):1135-7. PubMed ID: 11257654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphovascular invasion and the presence of more than three tumors are associated with poor outcomes of muscle-invasive bladder cancer after bladder-conserving therapies.
    Zhang M; Tao R; Zhang C; Shen Z
    Urology; 2010 Oct; 76(4):902-7. PubMed ID: 20709377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiotherapy for muscle-invasive carcinoma of the bladder: results of a randomized trial comparing conventional whole bladder with dose-escalated partial bladder radiotherapy.
    Cowan RA; McBain CA; Ryder WD; Wylie JP; Logue JP; Turner SL; Van der Voet J; Collins CD; Khoo VS; Read GR
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):197-207. PubMed ID: 15093917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cobalt therapy prophylaxis of recurrence of T1 bladder cancer.
    Pow-Sang J; Zaharia M; Ramirez G; Garcia J; Benavente V; Gonzales J
    Prog Clin Biol Res; 1984; 162B():33-7. PubMed ID: 6504903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiotherapy and cystectomy for T3 bladder carcinoma.
    Hall RR; Heath AB
    Br J Urol; 1981 Dec; 53(6):598-601. PubMed ID: 7317748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.
    George L; Bladou F; Bardou VJ; Gravis G; Tallet A; Alzieu C; Serment G; Salem N
    Urology; 2004 Sep; 64(3):488-93. PubMed ID: 15351577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized trial of radical radiotherapy for the management of pT1G3 NXM0 transitional cell carcinoma of the bladder.
    Harland SJ; Kynaston H; Grigor K; Wallace DM; Beacock C; Kockelbergh R; Clawson S; Barlow T; Parmar MK; Griffiths GO;
    J Urol; 2007 Sep; 178(3 Pt 1):807-13; discussion 813. PubMed ID: 17631326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morbidity after preoperative radiotherapy and cystectomy in patients with bladder cancer.
    Tomic R; Granfors T; Modig H
    Scand J Urol Nephrol; 1997 Apr; 31(2):149-53. PubMed ID: 9165578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoadjuvant intra-arterial doxorubicin chemotherapy in combination with low dose radiotherapy for the treatment of locally advanced transitional cell carcinoma of the bladder.
    Sumiyoshi Y; Yokota K; Akiyama M; Inoue Y; Yoneda F; Tsujimura H; Nakajima M; Yokozeki H; Maebayashi K
    J Urol; 1994 Aug; 152(2 Pt 1):362-6. PubMed ID: 8015072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.